Company profile: Life Science Connect
1.1 - Company Overview
Company description
- Provider of life science content marketing and sales enablement services, offering the Templeton Customer Insights Platform for purchasing journey insights and content optimization; the Follow Your Buyer Methodology; custom newsletters; Enhanced Lead Intelligence (ELI) reports; and content services including creation and distribution via webinars.
Products and services
- Enhanced Lead Intelligence (ELI) Reports: Customized reporting packages focusing on content engagement activity for key accounts, with reports centered on content engagement activity for designated accounts
- Follow Your Buyer Methodology: A methodology-based strategy that builds relationships and addresses customer challenges by supplying targeted content throughout the buyer’s journey
- Templeton Customer Insights Platform: A proprietary platform delivering actionable insights to understand purchasing journeys and optimize content marketing strategies.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Life Science Connect
Meridian Clinical Research
HQ: Germany
Website
- Description: Provider of a multi-specialty network that facilitates clinical trials for vaccines, drugs, medical devices & diagnostics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Meridian Clinical Research company profile →
Persano
HQ: Denmark
Website
- Description: Provider of manufactured cosmetics, dietary supplements, medical equipment, drugs, and health care products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Persano company profile →
WuXi Advanced Therapies
HQ: United States
Website
- Description: Provider of CDMO and integrated laboratory testing services to accelerate bio-based drugs, including TESSA scalable AAV vector production; XOFLX packaging and producer cell lines for lentiviral vectors; process development, IND-enabling studies, and phase-appropriate clinical manufacturing; plus comprehensive testing (viral clearance, biosafety, release, cell banking, stability) for cell and gene therapies, monoclonal antibodies, and vaccines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full WuXi Advanced Therapies company profile →
Tetris Pharma
HQ: United Kingdom
Website
- Description: Provider of a pan-European platform to market a range of prescription products, offered by a UK-based speciality pharmaceutical company with extensive experience of launching products in the UK and across Europe, focused on areas of unmet clinical need.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tetris Pharma company profile →
Padagis
HQ: United States
Website
- Description: Provider of generic Rx and OTC pharmaceuticals, including Brinzolamide Ophthalmic Suspension for ocular hypertension/open-angle glaucoma, Naloxone HCl Nasal Spray for opioid overdose, and extended topical prescription creams, ointments, suspensions, gels, foams, sprays, patches, nasal, and suppositories. Offers Paragraph IV specialty products and U.S. and Israel manufacturing and distribution across multiple dosage forms, including controlled substances.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Padagis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Life Science Connect
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Life Science Connect
2.2 - Growth funds investing in similar companies to Life Science Connect
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Life Science Connect
4.2 - Public trading comparable groups for Life Science Connect
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →